LEGALIZATION of DRUGS: the WRONG ANSWER TOA Ie COMPLEX PROBLEM ~ ~ I F ~( ~ T ~ I I ~ L ~ .~ I I
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
A Policy Perspective on the Global Use of Smokeless Tobacco
Curr Addict Rep DOI 10.1007/s40429-017-0166-7 TOBACCO (AH WEINBERGER, SECTION EDITOR) A Policy Perspective on the Global Use of Smokeless Tobacco Kamran Siddiqi1 & Aishwarya Lakshmi Vidyasagaran1 & Anne Readshaw1 & Ray Croucher2 # The Author(s) 2017. This article is an open access publication Abstract Keywords Smokeless tobacco . Snus . Tobacco control . Background Globally, over 300 million people consume di- Global health verse smokeless tobacco (ST) products. They are addictive, cause cancer, increased cardiovascular mortality risks and poor pregnancy outcomes. Introduction Purpose of Review To identify gaps in implementing key ST demand-reduction measures, focused literature reviews were “Smokeless tobacco” (ST) comprises tobacco products that do conducted and findings synthesized according to relevant not involve a combustion process, such as chewing, nasal and WHO Framework Convention on Tobacco Control (FCTC) oral tobacco [1•]. Globally, over 300 million people consume Articles. ST [1•], yet ST has been largely neglected in research and Recent Findings The literature supports implementation of policy arenas because it is generally regarded as less harmful ST demand-reduction measures. For taxation, labelling and than cigarettes. It is also seen as a regional rather than a global packaging, most administrations have weaker policies for ST problem, and too diverse and complex to control. than cigarettes. Capacity to regulate ST contents and offer ST use is reported in at least 116 countries worldwide, cessation support is lacking. There is poor compliance with including countries in Africa, Asia, Europe and the bans on ST advertising, promotion and sponsorship. Americas [2•]. Smokeless tobacco consumption is therefore Summary The literature on implementation of WHO a global public health issue. -
2020 International Narcotics Control Strategy Report
United States Department of State Bureau for International Narcotics and Law Enforcement Affairs International Narcotics Control Strategy Report Volume I Drug and Chemical Control March 2020 INCSR 2020 Volume 1 Table of Contents Table of Contents Common Abbreviations ..................................................................................................................................... iii International Agreements.................................................................................................................................... v INTRODUCTION ..................................................................................................................................... 1 Legislative Basis for the INCSR ......................................................................................................................... 2 Presidential Determination ................................................................................................................................. 7 Policy and Program Developments .................................................................................................... 12 Overview ......................................................................................................................................................... 13 Methodology for U.S. Government Estimates of Illegal Drug Production .......................................................... 18 Parties to UN Conventions .............................................................................................................................. -
Finland Country Drug Report 2017
Finland Country Drug Report 2017 Contents: At a glance | National drug strategy and coordination (p. 2) | Public expenditure (p. 3) | Drug laws and drug law offences (p. 4) | Drug use (p. 5) | Drug harms (p. 8) | Prevention (p. 10) | Harm reduction (p. 11) | Treatment (p. 12) | Drug use and responses in prison (p. 14) | Quality assurance (p. 15) | Drug-related research (p. 15) | Drug markets (p. 16) | Key drug statistics for Finland (p. 18) | EU Dashboard (p. 20) THE DRUG PROBLEM IN FINLAND AT A GLANCE Drug use Treatment entrants Overdose deaths Drug law offences in young adults (15-34 years) by primary drug in the last year 250 Cannabis 200 23 478 166 150 13.5 % Top 5 drugs seized 100 ranked according to quantities Cannabis, 21% 50 measured in kilograms Amphetamines, 15 % Cocaine, 0 % 0 1. Amphetamine 2011 2012 2013 2015 2014 Opioids, 52 % 2010 2007 2008 2006 9 % 17.9 % 2009 Other, 12 % 2. Herbal cannabis Other drugs Opioid substitution HIV diagnoses 3. Cannabis resin MDMA 2.5 % treatment clients attributed to injecting 4. Cocaine Amphetamines 2.4 % 14 5. Heroin Cocaine 1 % 12 3 000 10 Population 8 (15-64 years) 6 7 High-risk opioid users Syringes distributeddistributed 4 through specialised 2 3 483 757 programmes 0 13 836 2011 2012 2013 2015 2014 2010 2007 2008 2006 2009 Source: EUROSTAT (12 700 - 15 090) 5 301 000 Source: ECDC Extracted on: 26/03/2017 NB: Data presented here are either national estimates (prevalence of use, opioid drug users) or reported numbers through the EMCDDA indicators (treatment clients, syringes, deaths and HIV diagnosis, drug law offences and seizures). -
DEMAND REDUCTION a Glossary of Terms
UNITED NATIONS PUBLICATION Sales No. E.00.XI.9 ISBN: 92-1-148129-5 ACKNOWLEDGEMENTS This document was prepared by the: United Nations International Drug Control Programme (UNDCP), Vienna, Austria, in consultation with the Commonwealth of Health and Aged Care, Australia, and the informal international reference group. ii Contents Page Foreword . xi Demand reduction: A glossary of terms . 1 Abstinence . 1 Abuse . 1 Abuse liability . 2 Action research . 2 Addiction, addict . 2 Administration (method of) . 3 Adverse drug reaction . 4 Advice services . 4 Advocacy . 4 Agonist . 4 AIDS . 5 Al-Anon . 5 Alcohol . 5 Alcoholics Anonymous (AA) . 6 Alternatives to drug use . 6 Amfetamine . 6 Amotivational syndrome . 6 Amphetamine . 6 Amyl nitrate . 8 Analgesic . 8 iii Page Antagonist . 8 Anti-anxiety drug . 8 Antidepressant . 8 Backloading . 9 Bad trip . 9 Barbiturate . 9 Benzodiazepine . 10 Blood-borne virus . 10 Brief intervention . 11 Buprenorphine . 11 Caffeine . 12 Cannabis . 12 Chasing . 13 Cocaine . 13 Coca leaves . 14 Coca paste . 14 Cold turkey . 14 Community empowerment . 15 Co-morbidity . 15 Comprehensive Multidisciplinary Outline of Future Activities in Drug Abuse Control (CMO) . 15 Controlled substance . 15 Counselling and psychotherapy . 16 Court diversion . 16 Crash . 16 Cross-dependence . 17 Cross-tolerance . 17 Custody diversion . 17 Dance drug . 18 Decriminalization or depenalization . 18 Demand . 18 iv Page Demand reduction . 19 Dependence, dependence syndrome . 19 Dependence liability . 20 Depressant . 20 Designer drug . 20 Detoxification . 20 Diacetylmorphine/Diamorphine . 21 Diuretic . 21 Drug . 21 Drug abuse . 22 Drug abuse-related harm . 22 Drug abuse-related problem . 22 Drug policy . 23 Drug seeking . 23 Drug substitution . 23 Drug testing . 24 Drug use . -
Integration of Supply and Demand Reduction Strategies: Moving Beyond a Balanced Approach
E/INCB/2004/1 I. Integration of supply and demand reduction strategies: moving beyond a balanced approach 1. The ultimate goal of both supply and demand 1987 Comprehensive Multidisciplinary Outline of reduction strategies is the same: to minimize or Future Activities in Drug Abuse Control5 and in eliminate the use and abuse of illicit drugs. If that goal various resolutions of the General Assembly, the is attained, the development of substance use disorders Economic and Social Council and the Commission on and the health and social problems associated with Narcotic Drugs. them will also be reduced. Since the supply of and 6. The General Assembly at its twentieth special demand for illicit drugs are inextricably connected, session adopted the Declaration on the Guiding programmes aimed at reducing the drug problem Principles of Drug Demand Reduction (Assembly should be integrated, complementary and mutually resolution S-20/3, annex), in which it called for a reinforcing rather than isolated or competing activities. balanced approach between demand reduction and 2. Illicit drug use is a complex behaviour dependent supply reduction, each reinforcing the other, in an upon the individual, his or her environment and the integrated approach to solving the drug problem. The drugs themselves. Illicit drug markets at all levels are Joint Ministerial Statement and further measures to affected by the interaction between the demand for implement the action plans emanating from the drugs and their availability. The interaction is twentieth special session of the General Assembly, influenced by social, cultural, economic and political adopted during the ministerial segment of the forces. -
Framework Convention on Tobacco Control (WHO FCTC) Is the First Treaty Negotiated Under the Auspices of the World Health Organization
World Health Organization Geneva, Switzerland WHO FRAMEWORK CONVENTION ON TOBACCO CONTROL World Health Organization WHO Library Cataloguing-in-Publication Data WHO Framework Convention on Tobacco Control. 1.Tobacco - supply and distribution 2.Tobacco industry - legislation 3.Tobacco smoke pollution - prevention and control 4.Tobacco use cessation 5.Treaties I.World Health Organization. ISBN 92 4 159101 3 (LC/NLM classification: HD 9130.6) © World Health Organization 2003, updated reprint 2004, 2005 All rights reserved. Publications of the World Health Organization can be obtained from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel: +41 22 791 2476; fax: +41 22 791 4857; email: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press, at the above address (fax: +41 22 791 4806; email: [email protected]). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. -
COVID and Beyond Dart RC Opioid Abuse
Trends within Drug Abuse and Healthcare – COVID and Beyond Richard C. Dart, MD, PhD Director, Rocky Mountain Poison and Drug Safety, Denver Health Executive Director, RADARS® System Professor, University of Colorado School of Medicine Competing Interests RADARS® System is the property of The Denver Health and Hospital Authority (DHHA), a political subdivision of the State of Colorado. RADARS® System is supported by subscriptions from pharmaceutical manufacturers, government and nongovernment agencies for surveillance, research, and reporting services. No subscriber participated in the conception, analysis, drafting, or review of this presentation. 2 3 What Caused the US Opioid Crisis - HHS • In the late 1990s, pharmaceutical companies reassured the medical community that patients would not become addicted to opioid pain relievers and health care providers began to prescribe them at greater rates. • Increased prescription of opioid medications led to widespread misuse of both prescription and non-prescription opioids before it came clear that these medications could indeed be highly addictive. • 2017 HHS declared a public health emergency and announced a five point strategy to combat the opioid crisis https://www.hhs.gov/opioids/about-the-epidemic/index.html 4 What Really Happened? • Health care systems and regulation • Fifth vital sign, patient “satisfaction,” etc. • Careless doctors • We knew better, but let convenience win out. • Criminal behavior • Opioid marketing • Aggressive, irresponsible • Increased supply of illicit opioids • Lack of treatment for OUD • Good, but after the fact, insufficient to meet demand • Increased demand? 5 What Happened to Rx Drug Abuse? 10 Years ago… Prescription drug abuse is the Nation's fastest-growing drug problem, and the Centers for Disease Control and Prevention has classified prescription drug abuse as an epidemic. -
The Effects of Decriminalization of Drug Use in Portugal
CORE Metadata, citation and similar papers at core.ac.uk Provided by Kent Academic Repository BRIEFING PAPER FOURTEEN December 2007 THE BECKLEY FOUNDATION DRUG POLICY PROGRAMME THE EFFECTS OF DECRIMINALIZATION OF DRUG USE IN PORTUGAL Caitlin Hughes1 and Alex Stevens2 The Beckley Foundation Drug Policy Programme (BFDPP, www.internationaldrugpolicy.net) is a non-governmental initiative dedicated to providing a rigorous independent review of the effectiveness of national and international drug policies. The aim of this programme of research and analysis is to assemble and disseminate material that supports the rational consideration of complex drug policy issues, and leads to more effective management of the widespread use of psychoactive substances in the future. The Beckley Foundation Drug Policy Programme is a member of the International Drug Policy Consortium (IDPC, www. idpc.info), which is a global network of NGOs specialising in issues related to illegal drug use and government responses to the related problems. The Consortium aims to promote objective debate on the effectiveness, direction and content of drug policies at national and international level. INTRODUCTION THE 2001 CHANGES IN Portugal In 2004, the Beckley Foundation reported on the legal changes that In July 2001, Portugal introduced a new law, Law 30/2000, which took place in Portugal in 2001 (Allen, Trace & Klein 2004). This significantly changed the legal response to drug users. The new law report aims to provide an updated overview of the effects of these decriminalized the use, possession and acquisition of all types of changes, using data from the evaluations that have been carried out illicit substances for personal use, which was defined as being up to and from new interviews with key stakeholders in Portugal. -
Civil Society Monitoring of Harm Reduction in Europe, 2019
Correlation Correlation European DATA REPORT Eropean Harm Reduction R C Network C Network CIVIL SOCIETY MONITORING OF HARM REDUCTION IN EUROPE, 2019 DATA REPORT 1 CIVIL SOCIETY MONITORING OF HARM REDUCTION IN EUROPE, 2019 ® Correlation – European Harm Reduction Network, 2019. This publication of Correlation – European Harm Reduction Network is protected by copyright. Reproduction is authorised provided the source is acknowledged. Recommended citation: Tammi, T., Rigoni, R., Matičič, M., Schäffer, D., van der Gouwe, D., Schiffer, K., Perez Gayo, R., Schatz, E. (2020): Civil Society Monitoring of Harm Reduction in Europe, 2019. Data Report. Correlation European Harm Reduction Network, Amsterdam. Correlation – European Harm Reduction Network c/o Foundation De REGENBOOG GROEP Droogbak 1d 1013 GE Amsterdam The Netherlands www.correlation-net.org This project has been supported by the European Commission. Correlation - European Harm Reduction Network is co-funded by the European Union 2 Correlation European DATA REPORT Harm Reduction C Network CIVIL SOCIETY MONITORING OF HARM REDUCTION IN EUROPE, 2019 DATA REPORT 3 CIVIL SOCIETY MONITORING OF HARM REDUCTION IN EUROPE, 2019 CONTRIBUTORS Editor: The data network: Graham Shaw Albania: Genci Mucollari, Aksion Plus Austria: Alexandra Karden & Barbara Siokola, Scientific expert group: Suchthilfe Wien Tuukka Tammi (THL), Dagmar Hedrich (EMCDDA), Belgium: Peter Blanckaert & Tessa Windelinckx, Sam Shirley-Beavan (HRI), Perrine Roux (INSERM). Free Clinic Bosnia and Herzegovina: Samir Ibisevic, PROI -
The Impact of Drug Policy on Women
THE IMPACT OF DRUG POLICY ON WOMEN Kasia Malinowska-Sempruch & Olga Rychkova As member states of the United Nations take stock of the 02 INTRODUCTION drug control system, a number of debates have emerged among governments about how to balance international 03 WHAT THE UN AND OTHER INTERNATIONAL BODIES SAY drug laws with human rights, public health, alternatives to incarceration, and experimentation with regulation. 07 ISSUES RELEVANT TO UNGASS DEBATES This series intends to provide a primer on why governments 18 CONCLUSIONS AND RECOMMENDATIONS must not turn a blind eye to pressing human rights and public health impacts of current drug policies. 01 THE IMPACT OF DRUG POLICY ON WOMEN WHAT IS THE IMPACT OF DRUG POLICY ON WOMEN? “Who ever heard of a female drug lord? As the terms ‘kingpin’ and ‘drug lord’ denote, men are almost always at the head of major drug operations, and yet the rate of imprisonment of women for drug crimes has far outpaced that of men. Families and children suffer—but why?” –American Civil Liberties Union et al., Caught in the Net, 2005 1 1 American Civil Liberties Union (ACLU), Breaking the Chains and Brennan Center for Justice. Caught in the net: the impact of drug policies on women and families. New York, 2005. At: https://www.aclu.org/drug-law-reform/caught-net-impact-drug-policies-women-and-families. 02 THE IMPACT OF DRUG POLICY ON WOMEN INTRODUCTION In the public mind, the “war on drugs” probably conjures up a male image. In most countries, official statistics would show that men, indeed, are the majority of people who use drugs recreationally, who have problematic use, and who sell drugs. -
War on Drugs: Report of the Global Commission on Drug Policy
WAR ON DRUGS REPORT OF THE GLOBAL COMMISSION ON DRUG POLICY JUNE 2011 REPORT OF THE COMMISSIONERS GLOBAL COMMISSION Asma Jahangir, human rights activist, former UN Special Rapporteur on Arbitrary, Extrajudicial and ON DRUG POLICY Summary Executions, Pakistan Carlos Fuentes, writer and public intellectual, Mexico César Gaviria, former President of Colombia Ernesto Zedillo, former President of Mexico Fernando Henrique Cardoso, former President of To learn more about the Commission, visit: Brazil (chair) www.globalcommissionondrugs.org George Papandreou, Prime Minister of Greece Or email: [email protected] George P. Shultz, former Secretary of State, United States (honorary chair) Javier Solana, former European Union High Representative for the Common Foreign and Security Policy, Spain John Whitehead, banker and civil servant, chair of the World Trade Center Memorial Foundation, United States Kofi Annan, former Secretary General of the United Nations, Ghana Louise Arbour, former UN High Commissioner for Human Rights, President of the International Crisis Group, Canada Maria Cattaui, Petroplus Holdings Board member, former Secretary-General of the International Chamber of Commerce, Switzerland Mario Vargas Llosa, writer and public intellectual, Peru Marion Caspers-Merk, former State Secretary at the German Federal Ministry of Health Michel Kazatchkine, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, France Paul Volcker, former Chairman of the United States Federal Reserve and of the Economic Recovery Board Richard Branson, entrepreneur, advocate for social causes, founder of the Virgin Group, co-founder of The Elders, United Kingdom Ruth Dreifuss, former President of Switzerland and Minister of Home Affairs Thorvald Stoltenberg, former Minister of Foreign Affairs and UN High Commissioner for Refugees, Norway EXECUTIVE SUMMARY The global war on drugs has failed, with Our principles and recommendations can devastating consequences for individuals be summarized as follows: and societies around the world. -
Toward a More Effective Drug Policy Mathea Falco [email protected]
University of Chicago Legal Forum Volume 1994 | Issue 1 Article 3 Toward a More Effective Drug Policy Mathea Falco [email protected] Follow this and additional works at: http://chicagounbound.uchicago.edu/uclf Recommended Citation Falco, Mathea () "Toward a More Effective Drug Policy," University of Chicago Legal Forum: Vol. 1994: Iss. 1, Article 3. Available at: http://chicagounbound.uchicago.edu/uclf/vol1994/iss1/3 This Article is brought to you for free and open access by Chicago Unbound. It has been accepted for inclusion in University of Chicago Legal Forum by an authorized administrator of Chicago Unbound. For more information, please contact [email protected]. Toward a More Effective Drug Policy Mathea Falcot Although drug abuse is no longer front page news, America's drug problem is still very real. In 1992, the Office of Manage- ment and Budget estimated that drug abuse cost the nation $300 billion annually in lost productivity, crime, health care, and acci- dents.' Seventy-four million Americans acknowledge using illegal drugs; six million are believed to be so seriously addicted they require treatment.2 As many as 375,000 babies are born exposed every year; many of them are permanently damaged by their mothers' drug use.' If tobacco and alcohol are included as drugs of abuse, the toll is even greater. Together, they account for 490,000 deaths annually, and untold suffering for the users and their families.4 In an October 1993 report, the Institute for Health Policy at Brandeis University concluded that substance abuse is the single largest preventable cause of death in this country.' In the past decade, drug offenses have overwhelmed the criminal justice system.